Log in / Register
Home arrow Health arrow High Density Lipoproteins

A short course of lectures
«High Density Lipoproteins»

Preservation of Endothelial IntegrityApo A-I and S1P Confer Cardioprotective Effects on HDLImpact of Adiposity on HDL Concentration and FunctionNiacinHCV InfectionIn Vitro Effects of HDL on CardiomyocytesATP-Binding Cassette Transporter G1HDLs and Acute Stroke: Experimental ModelsRheumatoid Arthritis (RA)Transcriptional Regulation of the HDL Receptor SR-BIDyslipidemia in CKD PatientsHDL-Induced Cell Signaling Mediated by SR-BIInterference with Macrophage Differentiation and ActivationHDLs, Diabetes, and Metabolic SyndromeInflammatory DiseasesChanges of HDL Apolipoproteins (Modifications and Levels)Transcriptional Regulation of the CETP GeneLecithin/Cholesterol Acyltransferase (LCAT)Vaccines Against AtherosclerosisHDL in Infectious Diseases and SepsisApoA-I-Based Infusion TherapyHDL Biogenesis, Remodeling, and CatabolismLDL-Cholesterol Lowering Approaches: Proprotein Convertase Subtilisin/Kexin Type 9 Blocking AntibodiesIRI in In Vivo ModelsATI-5261Effect on HDL Ability to Preserve Endothelial Cell HomeostasisIV Treatments for Dyslipidemias and Dysfunction of HDLPreservation of Endothelial FunctionAntisense OligonucleotidesModified ApoA-IReconstituted HDLs and HDL MimeticsNovel PPAR AgonistsEffects on Cholesterol Efflux CapacityHDL Cholesterol as a Risk Factor for Other DiseasesI Physiology of HDL ApoE and apoA-IV Participate in the Biogenesis of HDL Particles Containing the Corresponding ProteinsFuture PerspectivesSystemic Lupus Erythematosus (SLE)PON1 and OrganophosphatesImpact of Anti-inflammatory TreatmentsApolipoprotein A-IMechanisms Under Physiological ConditionsStatinsAntithrombotic ActionsMechanisms Under Physiological ConditionsLaboratory Tests to Measure HDL FunctionEffects of Exercise on HDLRCT in Animal ModelsNiacinBiological MechanismsHeterogeneity of Antioxidant Activity of HDL ParticlesDetoxification of Plasma and External FluidsNiacinHDL and Viral InfectionsCholesterol Efflux and Reverse Cholesterol TransportTranscriptional Regulation of the Human apoM Gene in the LiverRegulation of HDL Genes: Transcriptional, Posttranscriptional, and Posttranslational: Pleiotropic Effects of HDLs—In Vitro and In Vivo DataMechanisms of ProtectionFibratesHDL SubclassesHDLs in the Cerebral CompartmentInteractions of HDLs with the EndotheliumTranscriptional Regulation of the ABCG1 GeneNiacinInteraction of HDL with LPS and Gram-Negative BacteriaThe Origin and Metabolism of Preb-HDL SubpopulationsBeyond the Genetics of HDL: Why Is HDL Cholesterol Inversely Related to Cardiovascular Disease?GeneralHDL and Reverse Cholesterol TransportHDL FractionsMechanisms Under Physiological ConditionsEstablished Secondary Regulators of Plasma HDL CholesterolTranscytosis of apoA-I and HDL by Endothelial CellsBiological MechanismsPhysiologyEmerging Small Molecule DrugsHDL Particle NumberBeneficial Effects of Selective HDL-Raising Gene Transfer on Cardiac Remodelling and Cardiac Function After Myocardial Infarction in MiceSources of FundingProteomeApoA-Iand HDL-Induced Cell Signaling Indirectly Mediated by ABCA1 and/or ABCG1ABCG1Scavenger Receptor BIDe Novo Synthesis of HDL and HDL BindingEffects of Established Hypolipidemic Drugs on HDL Concentration, Subclass Distribution, and FunctionTranscriptional Regulation of the Bile Acid Transporters ABCG5/ABCG8Lipoproteins in the BrainPleiotropic Effects of HDLsDoes HDL Play a Causal Role in the Pathogenesis of Diabetes?Effects of HDL on Insulin Sensitivity and Glucose Utilization by Skeletal MuscleInsulin Resistance, Hypertriglyceridemia, and Decreased HDL Cholesterol LevelsmiRNAsPrefaceBiogenesis of HDLTherapeutic Antisense Oligonucleotides for the Increase of HDL-Cholesterol Levels and Improvement of HDL FunctionEffects of Substituting Dietary Saturated Fatty AcidsHDL Particle SizeAtherothrombosisCholesterol Efflux to Lipidated HDLCholesterol Efflux as the First Step of Reverse Cholesterol Transport (RCT)Endothelial Cell Integrity, EPCs and Antiapoptotic ActionABCA1: HDLs and Acute Stroke (In Vivo Data)Structure of HDL: Particle Subclasses and Molecular ComponentsRelationship Between Lipid Raft Modulation and Lymphocyte FunctionIncrease of Molecules within HDL with a Fatal Function in the Vascular WallSmoking and HDL-C ConcentrationNiacinImpairment of the Endothelial Anti-Apoptotic Effects of HDL in Patients with Cardiovascular DiseaseEffect of HDL on StrokeHDL in the Test TubeTotal HDL-C in Various PopulationsHuman Apo A-I Gene Transfer Attenuates Diabetic CardiomyopathyProtective Effects of HDL on the KidneyType 2 Diabetes Mellitus and the Metabolic SyndromeStatinsApproaches to Antibody Therapy for the Increase of HDLCholesterol LevelsHDL LipidsHDL ProteomicsRVX-208Regulation of Genes Involved in HDL Metabolism at the Transcriptional LevelPosttranscriptional Modulation of HDL Metabolism by miRNAsVasculitisAntithrombotic Effects of HDLsFibratesApoA-I MimeticsEffects of HDLs on Vascular Lipid and Lipoprotein HomeostasisPharmacologyAlcohol Intake and HDL-C“Real” HDL ParticlesFFAs and Decreased HDL LevelsAnti-inflammatory EffectsPleiotropyPossibility of Functional Restoration of HDLMicromanaging Cholesterol Efflux, RCT, HDL Levels, and HDL FunctionapoMMetal Oxides, Carbon Nanotubes and PLGA NanoparticlesPurified ApoA-I InfusionsPON1 as an AntioxidantHDL and DietCurrent StateMacrophage Cholesterol Efflux and Reverse Cholesterol TransportHigh-Density Lipoprotein: Structural and Functional Changes Under Uremic Conditions and the Therapeutic ConsequencesDysfunctional HDL: From StructureFunction-Relationships to BiomarkersInsights from Intercrossing of the Different Knockout MiceTranscriptional Regulation of the PLTP GeneDietary MUFACholesteryl Ester Transfer ProteinThe Beneficial Effects of HDL in Pancreatic Beta CellsFCholesteryl Ester Transfer Protein InhibitorsRemodeling and Catabolism of HDLComplexity of HDLHDLs and Nitric Oxide (NO)General Innate Host Defense Mechanisms Exerted by HDL After Bacterial InfectionATP-Binding Cassette Transporter A1FibratesTranscriptional Regulation of the Apolipoprotein E GeneRole of Ecto-F1-ATPase/P2Y13 Pathway in Hepatic HDL ClearanceApoA-I Mimetic PeptidesFibratesCurrent StateII Pathology of HDLHDL and MycobacteriaThe Structure of HDLTherapeutic Potential of HDL in Cardioprotection and Tissue RepairATP-Binding Cassette Transporter G1Effects of HDL in Rat Neonatal CardiomyocytesFunctionality of HDL: Antioxidation and Detoxifying EffectsMyocardial InjuryAntibodiesStatinsImpaired Endothelial Anti-Inflammatory Effects of HDL in Patients with CAD, Diabetes, or Chronic Kidney DysfunctionHepatitis, Dengue and Other VirusesApoA-I-Induced Cell Signaling Indirectly Mediated by b-ATPase and P2Y12/13 ADP ReceptorLecithin-Cholesterol AcyltransferaseWeight LossLipid-Modulating Therapy in CKD PatientsFuture PerspectivesEffects on Plasma HDL-C ConcentrationPosttranslational Mechanisms of HDL RegulationHDL Confer Protection Against Ischaemia Reperfusion InjuryHuman Apo A-I Gene Transfer Reduces Diabetes-Induced Cardiac InflammationHDL-C in Diseases and ConditionsPhospholipid Transfer ProteinFibratesn-3 Polyunsaturated Fatty AcidsHigh-Density Lipoproteins, Paraoxonase-1Dysregulation of Proteins in HDL MetabolismHDL Cholesterol as a Risk Factor for Atherosclerosis and Its ComplicationsDevelopment of Topical HDL Therapy for Cutaneous Wound HealingSuppression of MyelopoiesisImpaired HDL Capacity to Stimulate NO Production in Patients with Cardiovascular DiseaseIRI in the Isolated Heart ModelAntisense Oligonucleotides, microRNAs, and AntibodiesHDL/apoA-I Structure and FunctionStatinsLow HDL Cholesterol Levels in Diabetes and Metabolic SyndromeEffects of Dietary Fatty Acids and Cholesterol on HDL FunctionPotential Mechanisms for the Smoking-Related Reduction in HDL-CHDL SubclassesHigh-Density Lipoproteins and Oxidative StressFuture PerspectivesHepatic Lipase and Endothelial LipaseIII Possible Indications and Target Mechanisms of HDL TherapyFuture Approaches of Epidemiological StudiesBacterial PathogensBiological MechanismsSuppression of Monocyte ExtravasationHDL-Induced Cell Signaling Mediated by S1PHuman Apo A-I Gene Transfer Influences Metabolic Parameters in Streptozotocin-Induced Diabetes MellitusChronic Kidney Disease: Epidemiology and PathophysiologyHDL and apoA-I as Members of the Innate Immune SystemBiological MechanismsEffects of Exercise on Prevention and Treatment of Cardiometabolic RiskDyslipidemia, Lipid-Modulating Therapy, and Cardiovascular Risk in CKD PatientsEffects of HDLs on Smooth Muscle CellsScavenger Receptor BISmoking CessationFX-5ACurrent StateHDL ApolipoproteinsAutoimmune Diseases: The Role of AutoantibodiesStructural and Functional Modifications of HDL in CKD PatientsInteraction of HDL with LTA and Gram-Positive BacteriaThe Role of Cubilin in apoA-I and HDL Catabolism by the KidneyEstablished Primary Regulators of Plasma HDL CholesterolABCA1-Mediated Lipid Efflux to Lipid-Poor apoA-IInhibition of LDL Modification by HDLsTranscriptional Regulation of the apoA-I Gene in the LiverPlasma HDLs in the BrainLipidomeEffects of Alcohol on HDL Atheroprotective FunctionsSelective DelipidationInflammatory Bowel DiseasesEffects of Alcohol on HDL and Cardiovascular RiskHDL and Bacterial InfectionsHuman Apo A-I Gene Transfer Attenuates DiabetesAssociated Oxidative Stress, Cardiac Fibrosis,miRNAs: Biogenesis and FunctionAdult Mouse CardiomyocytesEndothelial Anti-Inflammatory Effects of HDLMissing HeritabilityAnti-inflammatory and Antiprotease PropertiesClinical Relevance of the Aberrant HDL PhenotypesEffects of Regular Aerobic ExerciseHIV InfectionCSL-111 and CSL-112 InfusionsEffects of HDL on Endothelial Cell Apoptotic PathwaysProtective Role of HDL: Evidence from Epidemiological StudiesEffect of Weight-Loss Therapies on HDL Concentration and FunctionEpidemiology: Disease AssociationsMolecular Components of HDLFrom LDL Retention to Atheroma FormationmiRNA-Based TherapyMaking Sense of AntisenseEffects of HDL on ObesityAlterations of the Cholesterol Efflux Capacity of HDL in Cardiovascular DiseaseEffects on HDL Subclass DistributionHDL-Induced Cell Signaling: Future Challenges and OpportunitiesHDL Metabolism, Subclasses, and CatabolismHDL Protein Cargo and Prognostic BiomarkersStatinsHigh-Density Lipoproteins, Environmental Pathogens and ToxinsSignal Transduction by HDL: Agonists, Receptors, and Signaling CascadesHDL Quality and Cholesterol EffluxApo A-I and Sphingosine-1-Phosphate Mediate the Cytoprotective Effects of HDLPosttranscriptional Regulation of HDL Genes by Noncoding RNAs and microRNAsCarbohydrate and Extrinsic SugarsMouse Models of Disturbed HDL MetabolismHDL Potential Effects on the Blood–Brain BarrierApoA-I Mutations May Induce Hypertriglyceridemia and/or HypercholesterolemiaEffects of HDL on Endothelial Nitric Oxide BioavailabilityETC-642ATP-Binding Cassette Transporter A1 (ABCA1)HDL and Parasitic InfectionsFMechanisms Under Physiological ConditionsNovel Insight into HDL BiologySerum Cholesterol Efflux Capacity (CEC)Total HDL-C Modulated by Environmental FactorsHDL Conversion and RemodelingLoss of Protective Proteins or LipidsHDLs and Sphingosine 1-PhosphateEffect on HDL Antioxidant PropertiesPON1 and Bacterial PathogensCurrent StateTime Trends in Total HDL-CHDL-VHDL InfusionsHuman Apo A-I Gene Transfer Reduces Diabetes-Associated Cardiac Apoptosis and Improves the Cardiac Endothelial IntegrityEffect of Antibodies Used for the Treatment of Chronic Inflammatory Diseases on HDL Antiatherogenic FunctionsDeterminants of Plasma HDL Cholesterol LevelsParasitesAntioxidative StressImpairment of the Anti-Oxidative Effects of HDL in Patients After Surgery and With Cardiovascular DiseaseTranscriptional Regulation of the ABCA1 GeneAre There Other Biomarkers than the Total HDL-C?Mechanisms Under Physiological ConditionsEffects of HDL on LDL OxidationSmoking Cessation Intervention to Increase Plasma HDL ConcentrationNovel LXR AgonistsHigh HDL Levels Do Not Add to the ProtectionAcknowledgementHDL and Tissue Repair: Modulation of EPC Biology via SR-BICER-001 InfusionsImpact of Systemic Inflammation and Autoimmune Diseases on apoA-I and HDL Plasma Levels and FunctionsHDL FunctionApoA-I-Induced Cell Signaling Directly Mediated by ABCA1SR-BITherapeutic Antisense Oligonucleotides to Treat DyslipidemiaPsoriasisModulation of Spinghosine-1-Phosphate (S1P)/ S1P-Receptor Axis and Lymphocyte FunctionHDL and Atherothrombotic Vascular DiseaseCholesterol Ester Transfer Protein Transgenic MiceHDL and Lifestyle InterventionsHigh-Density Lipoproteins in StrokePhospholipid Transfer ProteinHigh-Density Lipoproteins: Antioxidative Function
Found a mistake? Please highlight the word and press Shift + Enter  
Business & Finance
Computer Science
Language & Literature
Political science